Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar bIlluminati (30.30) Submitted: 11/16/2012 1:47:26 PM : Underperform Start Price: $24.64 ASTM Score: +9.78

Not profitable.

Featured Broker Partners


Advertisement